2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
12
Breast Neoplasms
11
Lung Neoplasms
6
Prostatic Neoplasms
5
Colorectal Neoplasms
5
Uterine Cervical Neoplasms
4
Thyroid Neoplasms
2
Smoking Cessation
2
Motor Activity
2
Lymphoma
2
Hematologic Neoplasms
2
Communication
2
Uveal Melanoma
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Tobacco Use Disorder
1
Tobacco Use Cessation
1
Thyroid Diseases
1
Substance-Related Disorders
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Sexual Dysfunction, Physiological
1
Sedentary Behavior
1
Rectal Neoplasms
1
Patient Preference
1
Patient Acceptance of Health Care
1
Papillomavirus Infections
1
Papillary Thyroid Microcarcinoma
1
Neoplasms, Plasma Cell
1
Interventions
Dexamethasone
809
Bortezomib
449
Lenalidomide
430
Cyclophosphamide
336
Melphalan
251
Calcium Dobesilate
237
daratumumab
218
pomalidomide
202
carfilzomib
181
fludarabine phosphate
131
Thalidomide
121
fludarabine
118
Peripheral Blood Stem Cell Transplantation
117
Filgrastim
111
ixazomib
85
Mycophenolic Acid
85
Granulocyte Colony-Stimulating Factor
84
Busulfan
83
Whole-Body Irradiation
80
Tacrolimus
75
dexamethasone acetate
74
Cyclosporine
67
isatuximab
64
Prednisone
64
dexamethasone 21-phosphate
63
elotuzumab
60
auricularum
57
belantamab mafodotin
55
Antilymphocyte Serum
55
Etoposide
52
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
Focus Groups
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled